NEW YORK, Sept 27 – As genomics software company Genomica of Boulder Colo., gears up for an expected $85 million IPO this week, it said Wednesday that it had licensed its Discovery Manager software to Genome Therapeutics (Nasdaq: GENE).  

Financial terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.